DYN
Price
$34.34
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
42 days until earnings call
PTCT
Price
$35.48
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
35 days until earnings call
Ad is loading...

DYN vs PTCT

Header iconDYN vs PTCT Comparison
Open Charts DYN vs PTCTBanner chart's image
Dyne Therapeutics
Price$34.34
Change-$0.00 (-0.00%)
Volume$1.06M
CapitalizationN/A
PTC Therapeutics
Price$35.48
Change-$0.00 (-0.00%)
Volume$608.89K
CapitalizationN/A
View a ticker or compare two or three
DYN vs PTCT Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DYN vs. PTCT commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongSell and PTCT is a StrongBuy.

COMPARISON
Comparison
Sep 20, 2024
Stock price -- (DYN: $34.34 vs. PTCT: $35.48)
Brand notoriety: DYN and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 82% vs. PTCT: 104%
Market capitalization -- DYN: $3.45B vs. PTCT: $2.73B
DYN [@Biotechnology] is valued at $3.45B. PTCT’s [@Biotechnology] market capitalization is $2.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $585.36B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green whilePTCT’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • PTCT’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than PTCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while PTCT’s TA Score has 6 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • PTCT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PTCT is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +5.34% price change this week, while PTCT (@Biotechnology) price change was +9.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.38%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1.46%.

Reported Earning Dates

DYN is expected to report earnings on Oct 31, 2024.

PTCT is expected to report earnings on Oct 24, 2024.

Industries' Descriptions

@Biotechnology (+7.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.45B) has a higher market cap than PTCT($2.73B). DYN YTD gains are higher at: 158.196 vs. PTCT (28.737). PTCT has higher annual earnings (EBITDA): -132.14M vs. DYN (-269.47M). PTCT has more cash in the bank: 1.09B vs. DYN (779M). DYN has less debt than PTCT: DYN (25.7M) vs PTCT (396M). PTCT has higher revenues than DYN: PTCT (900M) vs DYN (0).
DYNPTCTDYN / PTCT
Capitalization3.45B2.73B126%
EBITDA-269.47M-132.14M204%
Gain YTD158.19628.737550%
P/E RatioN/AN/A-
Revenue0900M-
Total Cash779M1.09B71%
Total Debt25.7M396M6%
FUNDAMENTALS RATINGS
PTCT: Fundamental Ratings
PTCT
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNPTCT
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIFX29.08N/A
N/A
Goldman Sachs International Eq ESG A
VIVAX67.23-0.14
-0.21%
Vanguard Value Index Inv
DCSVX13.21-0.03
-0.23%
Dunham Small Cap Value C
WTRCX13.24-0.04
-0.30%
Delaware Ivy Core Equity Fund Class C
GLECX13.59-0.05
-0.37%
GS Energy Infrastructure Fd C Shares

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-0.75%
RNA - DYN
50%
Loosely correlated
+5.81%
KYMR - DYN
46%
Loosely correlated
-1.80%
AXON - DYN
43%
Loosely correlated
+0.15%
RXRX - DYN
42%
Loosely correlated
+2.07%
ENTA - DYN
42%
Loosely correlated
-2.23%
More

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with ABOS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
+1.17%
ABOS - PTCT
41%
Loosely correlated
-1.41%
NTLA - PTCT
40%
Loosely correlated
-0.13%
INZY - PTCT
39%
Loosely correlated
-0.17%
DYN - PTCT
38%
Loosely correlated
-0.75%
CPRX - PTCT
38%
Loosely correlated
-0.05%
More